New targets in the fight against pancreatic cancer


Pancreatic cancer remains one of the deadliest malignancies worldwide. Since five-year survival rate for pancreatic ductal adenocarcinoma (PDAC) is only about 3% in patients, PDAC is very difficult to treat with surgery worldwide. To develop novel treatment methods, the biology of PDAC at the molecular level needs to be better understood.

Problems with alcohol use after weight-loss surgery in adolescence

Previous article

Taking pride in identity may protect mental health against online hate, study about experience of Asian Americans finds

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations